Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional study.
Manoj Vasanth MurhekarTarun BhatnagarJeromie Wesley Vivian ThangarajV SaravanakumarMuthusamy Santhosh KumarSriram SelvarajuKiran RadeC P Girish KumarR SabarinathanSmita AsthanaRakesh BalachandarSampada Dipak BangarAvi Kumar BansalJyothi BhatDebjit ChakrabortyVishal ChopraDasarathi DasKangjam Rekha DeviGaurav Raj DwivediAgam JainS Muhammad Salim KhanM Sunil KumarAvula LaxmaiahMajor MadhukarAmarendra MahapatraTalluri RameshChethana RangarajuJyotirmayee TurukSuresh YadavBalram Bhargavanull nullPublished in: PLoS medicine (2021)
Nearly two-thirds of individuals aged ≥6 years from the general population and 85% of HCWs had antibodies against SARS-CoV-2 by June-July 2021 in India. As one-third of the population is still seronegative, it is necessary to accelerate the coverage of COVID-19 vaccination among adults and continue adherence to non-pharmaceutical interventions.